R K Swamy Limited — Updates, 21-05-2025: Press Release

R K Swamy has announced a board meeting to review the financial results for the quarter and half-year. The company rolled out nine growth initiatives in FY25, including a market study center, enhanced customer experience capabilities, AI adoption, and scaling pharma services. Consolidated revenue dipped 8.7% to Rs 306.15 Cr, hit by fewer one-off projects. However, significant investments in growth led to a 53.8% fall in consolidated PBT to Rs 24.77 Cr, underscoring management’s focus on long-term opportunities.